Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11939346-B2 United States of America 26 Mar 2024
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11851451-B2 United States of America 26 Dec 2023
Protective alkyl tryptamines and their therapeutic uses Application KR-20230130664-A Republic of Korea 12 Sep 2023
Method for treating anxiety disorders, headache disorders, and eating disorders with… Grant US-11738035-B2 United States of America 29 Aug 2023
TREATING ALCOHOL USE DISORDER USING PSILOCYBIN Application WO-2023137325-A1 World Intellectual Property Organisation (WIPO) 20 Jul 2023
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11629159-B2 United States of America 18 Apr 2023
Method for treating anxiety disorders, headache disorders, and eating disorders with… Grant US-11564935-B2 United States of America 31 Jan 2023
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11505564-B2 United States of America 22 Nov 2022
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11447510-B2 United States of America 20 Sep 2022
SYSTEMS AND METHODS FOR PHARMACEUTICAL PRODUCTION OF PSILOCYBIN AND INTERMEDIATES OR SIDE… Application WO-2022150854-A1 World Intellectual Property Organisation (WIPO) 14 Jul 2022
Crystalline N-methyl tryptamine derivatives Grant US-11332441-B2 United States of America 17 May 2022
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11180517-B2 United States of America 23 Nov 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11149044-B2 United States of America 19 Oct 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-10954259-B1 United States of America 23 Mar 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-10947257-B2 United States of America 16 Mar 2021
ORAL DISSOLVABLE FILM CONTAINING PSYCHEDELIC COMPOUND Application US-20210015738-A1 United States of America 21 Jan 2021